| Literature DB >> 29351774 |
Berit Boshuizen1,2, Margreet Ploeg3, Jeroen Dewulf4, Sanne Klooster5, Marco de Bruijn2, Marie- Thérèse Picavet6, Katrien Palmers7, Lukas Plancke1, Hilde De Cock8, Mathijs Theelen5, Catherine Delesalle9.
Abstract
BACKGROUND: Diagnosing IBD in horses is challenging and requires a multimodal approach, since no conclusive diagnostic test is available. The objectives of this study were to provide an overview of population characteristics, results of applied diagnostic tests, treatment modalities and outcome in a large group of horses thought to have IBD and that were presented to four large equine referral hospitals, and to provide an exploratory investigation of possible associations between results of applied diagnostic tests, applied treatment modalities and outcome. A retrospective case series was performed across four large equine referral hospitals. Seventy-eight horses, thought to have IBD were included. Case history, clinical findings, diagnostic test results including oral glucose tolerance test (OGTT) and enteral biopsies (both duodenal and rectal), applied therapy and outcome were studied. A Chi-Square test was used to identify associations between results of diagnostic tests, treatment and outcome. P-values < 0.05 were considered significant.Entities:
Keywords: Chronic enteritis; Colic; Duodenal biopsy; Equine; Oral glucose tolerance test; Weight loss
Mesh:
Substances:
Year: 2018 PMID: 29351774 PMCID: PMC5775604 DOI: 10.1186/s12917-018-1343-1
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Applied reference ranges for tested complete blood count (CBC) and serum chemistry parameters per referral centre
| referral centre 1 | referral centre 2 | referral centre 3 and 4 | % of study population out of reference | |
|---|---|---|---|---|
| Total Protein | 52–79 g/L | 62–94 g/L | 52–67 g/L | 11.6% ↓ |
| Albumin | 26–37 g/L | 23–35 g/L | 25–39 g/L | 8.7% ↓ |
| Gamma globulin | 6–19 g/L | 4,6–13,4 g/L | 7,9–17,9 g/L | 4.5% ↑ |
| Gamma-GT | < 20 U/L | 16–56 U/L | < 22 U/L | 23.0% ↑ |
| PCV | 0,32–0,42 L/L | 0,32–0,52 L/L | 0,30–0,46 L/L | 17.9% ↓ |
| Leucocytes | 7,0–10,0 10^9/L | 5,5–12,5 10^9/L | 5,0–10,0 10^9/L | 23.9% ↑ |
Detailed overview of the quality assessment of enteral biopsies across involved pathology labs
| Duodenal biopsies | Rectal biopsies | |
|---|---|---|
| Total number of biopsies | 100% ( | 100% ( |
| Good quality diagnostic material | 0% ( | 0% (n = 0) |
| Moderate quality | 56.8% (n = 21) | 93.3% (n = 42) |
| Poor quality | 18.9% ( | 0% (n = 0) |
| Insufficient quality to assess | 24,3% (n = 9) | 6,7% (n = 3) |
Detailed overview of the histopathological classification of the enteral biopsies
| OGTT > 85% (normal) | OGTT < 85% (abnormal) | |||
|---|---|---|---|---|
| Duodenum | Rectum | Duodenum | Rectum | |
| Normal | 1 | 4 | 4 | 1 |
| Granulomatous enteritis | 0 | 0 | 4 | 0 |
| Eosinophilic enteritis | 1 | 9 | 2 | 13 |
| Lymphocytic plasmacytic enteritis or proctitis | 5 | 15 | 11 | 21 |
| Neutrophilic inflammation | 0 | 1 | 0 | 2 |